POSB197 Impact of Immune Checkpoint Inhibitors (ICIS) on the Management of Advanced Non-Small Cell Lung Cancer (NSCLC) in Real-World Practice at Karolinska University Hospital, Stockholm between 2012 and 2018
Abstract
Authors
S Ekman OT Brustugun JB Sørensen AM Kejs Q Ann M Bortolini A Calleja L Rosengren P Huetson MJ Daumont JR Penrod HC Jacobs L Lacoin H Koyi